about
Worldwide Incidence of Colorectal Cancer, Leukemia, and Lymphoma in Inflammatory Bowel Disease: An Updated Systematic Review and Meta-AnalysisUse of Thiopurines in Inflammatory Bowel Disease: A Consensus Statement by the Korean Association for the Study of Intestinal Diseases (KASID)Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectivesDiagnostic Difficulties in Woman with Crohn's Disease, Ascites, and Elevated Value of Serum CA125 AntigenUse of thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel diseases: a meta-analysis.IBD LIVE Case Series-Case 2: Previous Cancer in a Patient with Crohn's Disease: Is It Appropriate to Use Biologics and Immunosuppressants for IBD Treatment?Eccrine Porocarcinoma presenting as an abdominal wall mass in a patient with ulcerative colitis-A rare case report.Risk of lymphoma subtypes after solid organ transplantation in the United States.Investigation of mitigating effect of colon-specific prodrugs of boswellic acid on 2,4,6-trinitrobenzene sulfonic acid-induced colitis in Wistar rats: Design, kinetics and biological evaluation.The management of immunosuppression in patients with inflammatory bowel disease and cancer.Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-α therapy in inflammatory bowel disease.Biological therapy for ulcerative colitis.Hepatosplenic T-cell lymphoma in a 47-year-old Crohn's disease patient on thiopurine monotherapy.Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort.Adalimumab therapy in a patient with Crohn's disease with a giant pelvic paraganglioma after chemotherapy.Exploring the interplay between autoimmunity and cancer to find the target therapeutic hotspots.Short-term effect and adverse events of adalimumab versus placebo in inducing remission for moderate-to-severe ulcerative colitis: a meta-analysis.Oral delivery of siRNA lipid nanoparticles: Fate in the GI tract.IBD LIVE Series-Case 8: Treatment Options for Refractory Esophageal Crohn's Disease and Hidradenitis Suppurativa.
P2860
Q26746994-FCE7ECC1-B405-4218-8AFC-452ACFBCA46AQ26996946-E78B4565-D338-4FEC-8779-7EE8CE498C26Q28085134-B137B977-D70B-4081-879B-5512FA0C50C8Q34651710-F7767090-70B5-4E0C-AA44-2B7BDFC5B1E5Q35060557-0CDC2323-2594-482B-B2ED-8DEC066EE9A6Q35670762-30D0A0A7-BDDF-4C41-97F2-CA87C374DABCQ36865581-BAFDEC74-62F4-432D-BE38-1887B0236686Q37003308-9837849A-989D-4B06-B6B4-31A4E34E89A2Q37662616-89B2D45A-D05C-470B-93FD-6FD022B57144Q38125570-19F2033C-C0AB-4A77-87BF-4F58B5E12087Q38180195-C579353F-8FE0-4FC6-84D9-6D85F83EFF68Q38262662-9CB7C335-BC0F-44F7-8F89-FCC7D144CF90Q39615429-96DD3BB5-41AF-4293-AE69-B012C251FA76Q39773210-C65DAE8F-672F-4D44-99FF-12FE864BCD0BQ40066358-28DBCF98-3ED6-41B4-A066-F6838C343C14Q40144087-2ACE01EE-8555-4C64-97CF-39141CECA93EQ41807889-730F80F2-3A7F-4E22-953B-7C50248B6282Q48120325-D43CC621-CD2A-45AE-9A52-B2439CADD33EQ50106362-103DEB29-A0BE-4165-85CA-B9FCE8C43363
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Do inflammatory bowel disease therapies cause cancer?
@ast
Do inflammatory bowel disease therapies cause cancer?
@en
Do inflammatory bowel disease therapies cause cancer?
@nl
type
label
Do inflammatory bowel disease therapies cause cancer?
@ast
Do inflammatory bowel disease therapies cause cancer?
@en
Do inflammatory bowel disease therapies cause cancer?
@nl
prefLabel
Do inflammatory bowel disease therapies cause cancer?
@ast
Do inflammatory bowel disease therapies cause cancer?
@en
Do inflammatory bowel disease therapies cause cancer?
@nl
P2860
P1476
Do inflammatory bowel disease therapies cause cancer?
@en
P2093
Corey A Siegel
Mysha Mason
P2860
P304
P356
10.1097/MIB.0B013E3182807618
P577
2013-05-01T00:00:00Z